Historical record - last NADAC publication: 4/17/2024
Product Information
AMPICILLIN 2 GM VIAL is a generic product labeled by Civica, Inc., priced at $3.2338 per EA under NDC 72572001710. Its NADAC has been published 53 times since Apr 17, 2024.
Strength
2 g/1
Manufacturer
Civica, Inc.NDC
72572001710
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
4/17/2024
Active Ingredients
AMPICILLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA062797On Market Since
12/1/2020
Pharmacological Classes
Price Statistics
The NADAC for AMPICILLIN 2 GM VIAL has been published 53 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2338 per EA |
|---|---|
| All-time high | $3.2338 (Apr 16, 2025) |
| All-time low | $3.2338 (Apr 17, 2024) |
| Median price | $3.2338 |
| Average price | $3.2338 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 53 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMPICILLIN 2 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMPICILLIN 2 GM VIAL, manufactured by Civica, Inc., is $3.2338 per EA (NDC 72572001710), effective Apr 16, 2025.
How has the price of AMPICILLIN 2 GM VIAL changed over time?
Over the history we have for it, the NADAC for AMPICILLIN 2 GM VIAL has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AMPICILLIN 2 GM VIAL?
Since Apr 17, 2024, the NADAC for AMPICILLIN 2 GM VIAL has ranged from a low of $3.2338 (Apr 17, 2024) to a high of $3.2338 (Apr 16, 2025), with a median of $3.2338 per EA.
Are there cheaper alternatives to AMPICILLIN 2 GM VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMPICILLIN 2 GM VIAL, but none are currently priced below it.
Who manufactures AMPICILLIN 2 GM VIAL?
AMPICILLIN 2 GM VIAL (NDC 72572001710) is labeled by Civica, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification